GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Privia Health Group Inc (NAS:PRVA) » Definitions » EBITDA

PRVA (Privia Health Group) EBITDA : $24 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Privia Health Group EBITDA?

Privia Health Group's EBITDA for the three months ended in Dec. 2024 was $7 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was $24 Mil.

During the past 12 months, the average EBITDA Growth Rate of Privia Health Group was -10.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 7 years, the highest 3-Year average EBITDA Growth Rate of Privia Health Group was -0.10% per year. The lowest was -0.10% per year. And the median was -0.10% per year.

Privia Health Group's EBITDA per Share for the three months ended in Dec. 2024 was $0.06. Its EBITDA per share for the trailing twelve months (TTM) ended in Dec. 2024 was $0.19.

During the past 12 months, the average EBITDA per Share Growth Rate of Privia Health Group was -11.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 7 years, the highest 3-Year average EBITDA per Share Growth Rate of Privia Health Group was -6.30% per year. The lowest was -6.30% per year. And the median was -6.30% per year.


Privia Health Group EBITDA Historical Data

The historical data trend for Privia Health Group's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Privia Health Group EBITDA Chart

Privia Health Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA
Get a 7-Day Free Trial 27.22 -214.97 -14.55 27.18 24.25

Privia Health Group Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.19 2.64 6.92 7.61 7.08

Competitive Comparison of Privia Health Group's EBITDA

For the Health Information Services subindustry, Privia Health Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Privia Health Group's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Privia Health Group's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Privia Health Group's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Privia Health Group's EBITDA for the fiscal year that ended in Dec. 2024 is calculated as

Privia Health Group's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2024, Privia Health Group's EBITDA was $24 Mil.

Privia Health Group's EBITDA for the quarter that ended in Dec. 2024 is calculated as

Privia Health Group's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Dec. 2024, Privia Health Group's EBITDA was $7 Mil.

EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Privia Health Group  (NAS:PRVA) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Privia Health Group EBITDA Related Terms

Thank you for viewing the detailed overview of Privia Health Group's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Privia Health Group Business Description

Traded in Other Exchanges
N/A
Address
950 North Glebe Road, Suite 700, Arlington, VA, USA, 22203
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
Executives
David Mountcastle officer: Chief Financial Officer 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Parth Mehrotra officer: President and COO 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Adam Boehler director 1215 5TH AVE N,, NASHVILLE TN 37208
Thomas A Mccarthy director 1601 CHESTNUT STREET, SHAREHOLDER SERVICES TL18Y, PHILADELPHIA PA 19192
Thomas Bartrum officer: EVP, General Counsel 950 N. GLEBE RD., SUITE 700, ALEXANDRIA VA 22203
Matthew Shawn Morris director, officer: Chief Executive Officer 950 N. GLEBE ST., SUITE 700, ARLINGTON VA 22203
William M Sullivan director ONE PENN PLAZA, SUITE 5300, NY NY 10119
Pamela O Kimmet director 11207 ORANGE HIBISCUS LANE, PALM BEACH GARDENS FL 33418
David S Wichmann director BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Jeffrey Daniel Bernstein director 200 WEST STREET, NEW YORK NY 10282
Pamplona Capital Partners Iii, L.p. 10 percent owner 94 SOLARIS AVENUE, CAMANA BAY, P.O. BOX 1348, GRAND CAYMAN E9 KY1-1108
Mbd Advisors, L.l.c. 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Jeffrey B Butler director 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22101
David P King director PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203